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Chronic treatment with a smart 
antioxidative nanoparticle for 
inhibition of amyloid plaque 
propagation in Tg2576 mouse 
model of Alzheimer’s disease
Phetcharat Boonruamkaew1,5, Pennapa Chonpathompikunlert1,6, Long Binh Vong1,7, Sho 
Sakaue1, Yasushi Tomidokoro2, Kazuhiro Ishii2, Akira Tamaoka2,3 & Yukio Nagasaki1,3,4
The present study aimed to assess whether our newly developed redox nanoparticle (RNPN) that has 
antioxidant potential decreases Aβ levels or prevents Aβ aggregation associated with oxidative stress. 
The transgenic Tg2576 Alzheimer’s disease (AD) mice were used to investigate the effect of chronic ad 
libitum drinking of RNPN solution for 6 months, including memory and learning functions, antioxidant 
activity, and amyloid plaque aggregation. The results showed that RNPN-treated mice had significantly 
attenuated cognitive deficits of both spatial and non-spatial memories, reduced oxidative stress of 
lipid peroxide, and DNA oxidation. RNPN treatment increased the percent inhibition of superoxide 
anion and glutathione peroxidase activity, neuronal densities in the cortex and hippocampus, 
decreased Aβ(1-40), Aβ(1-42) and gamma (γ)-secretase levels, and reduced Aβ plaque observed 
using immunohistochemistry analysis and thioflavin S staining. Our results suggest that RNPN may 
be a promising candidate for AD therapy because of its antioxidant properties and reduction in Aβ 
aggregation, thereby suppressing its adverse side effect.
The number of patients affected with Alzheimer’s disease (AD) is increasing1. AD is a slow progressing, neuro-
degenerative disorder, which exhibits the cardinal hallmarks of amyloid beta (Aβ) plaques accumulation and 
neurofibrillary tangles. In addition, the loss of synapses, atrophy of the cerebral cortex, neuroinflammation, and 
increase in free radicals in patients with AD is also reported2.
In the progression of AD, the conformation and misfolding of Aβ proteins causes them to clump together into 
small oligomers, protofibrils, and mature fibrils3. The soluble oligomers are structurally heterogeneous, which 
have been determined as the main toxic forms in AD4. The oligomer-induced toxicity of the cell is related to its 
ability to permeabilize cellular membranes and lipid bilayers5 to form distinct pores or single channels in the 
membranes6 and disturb intracellular calcium homeostasis, leading to oxidative stress including overproduction 
of reactive oxygen species (ROS), altered signaling pathways, mitochondrial dysfunction, and neuronal death7.
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Currently, one of the most promising strategies for AD therapy is to decrease Aβ aggregation, especially Aβ(1-
42) and/or destroy the oligomers and fibrils formed in the brain8, 9. Previous studies have proposed an effective 
inhibitor of Aβ, Quercetin, which blocks the formation of fibrils, including the inhibition of Aβ aggregation10, 
reduction in ROS production11, and alteration in the functions of immune and inflammatory cells12. Therefore, 
there are several targets such as inhibition of Aβ aggregation, and Aβ-induced oxidative stress, especially ROS, to 
improve therapeutic and preventive strategies for the development of disease-modifying drugs for AD.
Antioxidants are widely used to scavenge ROS13, 14. Although versatile antioxidants such as vitamin C and E, 
many phytochemicals, and synthetic drugs have been developed so far, none of them work effectively. One of the 
serious issues in the use of antioxidants is the dysfunction of normal redox reaction in healthy cells, including the 
electron transport chain due to the internalization of these low-molecular-weight (LMW) antioxidants because 
of their size. This undesired adverse side effect limits the effective dosage of these LMW antioxidants. Recently, 
we designed polymer antioxidants, where the antioxidant moieties are covalently bound to the amphiphilic block 
copolymer backbone. Due to the high molecular weight, the internalization of these polymer antioxidants is 
decreased in healthy cells and their mitochondria, which significantly reduce its adverse effects15, 16.
We designed the polymer poly(ethylene glycol)-b-poly[4-(2,2,6,6-tetramethylpiperidine-1-oxyl)ami-
nomethylstyrene] (PEG-b-PMNT). The PEG segment is water-soluble part, while PMNT is the water-insoluble 
part. Thus, it forms a polymer micelle of several tens of nanometer size in transparent aqueous media (we abbre-
viate it as RNPN, as shown in Supplementary Figure 1). The 2,2,6,6-tetramethylpiperidine-1-oxyl (so called 
TEMPO) groups as a side chain of the PMNT segment is known to be a stable radical and does not react with each 
other. However, it catalytically reacts with ROS and is regarded as one of the strongest antioxidants17. Because 
the PMNT segment possesses repeating amino groups, it protonates in response to pH decrease and becomes 
hydrophilic to result in disintegration under acidic conditions15, 18, 19. After oral administration of RNPN solu-
tion, it disintegrates in the stomach, and the disintegrated antioxidant polymer is absorbed in the bloodstream 
from the small intestine because the total molecular weight of the polymer was limited to around 7–20 kDa19. 
We have previously confirmed that our redox nanoparticle exhibits an anti-apoptotic effect on Aβ-induced cell 
death in vitro20. We have also confirmed that oral administration of RNPN showed an antioxidant effect on the 
brain of senescence-accelerated (SAMP8) mice and did not exhibit any detectable toxicity in the vital organs after 
continuous administration for 1 month19. The objective of this work was to confirm the effectiveness of RNPN in 
transgenic AD mice model (Tg2576) for an extended time by ad libitum drinking of RNPN for the prevention of 
Aβ accumulation in Tg2576 mice overexpressing a mutant form of amyloid precursor protein (APP).
Results
Delivery of redox polymer to the blood and brain by chronic ad libitum drinking of RNPN solu-
tion. To confirm the uptake of the redox polymer in the blood by oral administration, electron spin reso-
nance (ESR) measurements of the blood and brain were carried out. The ESR signal of LMW TEMPO derivatives 
showed a triplet signal due to the coupling between the unpaired electron on oxygen and 14N nuclei (Fig. 1A). 
After ad libitum drinking of LMW TEMPO, the triplet signal was clearly observed in both the blood and brain 
samples as observed in the standard solution (Fig. 1B,C). We have previously reported that the ESR pattern of an 
aqueous solution of RNPN does not appear as a typical triplet signal but as broadened spectra as shown in Fig. 1D. 
When RNPN was mixed with untreated brain, and the homogenate was analyzed by ESR measurement, the broad-
ened spectrum was observed, similar to RNPN in saline solution (Fig. 1E). After ad libitum drinking of RNPN 
solution, small but definite signal was observed in the homogenized brain samples, although the signal pattern 
changed from broad ESR spectra (Fig. 1E) to triplet signal in both the blood and brain samples (Fig. 1F and G), 
indicating the disintegration of RNPN in the stomach to result in the uptake of redox polymer in the bloodstream 
and brain tissues. These results were consistent with the quantitative analysis of ESR spectra intensities as dis-
played in Supplementary Table S1.
Effect of redox polymer on learning and memory deficit in transgenic mice expressing mutant 
APP. We analyzed the recovery of learning and memory functions in transgenic mice expressing APP in the 
brain as shown in Fig. 2. In the object recognition and location memory tests, the time period was lower for AD 
mice aged around 10–11 months, compared with the wild type group while in the groups treated with LMW 
TEMPO and nRNP, which is a polymer micelle without TEMPO moiety, the exploration time and discrimination 
index did not increase. In contrast, the exploration time and discrimination index for the RNPN-treated group 
significantly increased compared with other treated groups for both the object recognition and location tests 
(Fig. 2A–D). Furthermore, the effect of RNPN on object recognition test after 24 h also displayed the same pattern 
as after 1 h of ad libitum drinking (Figure S4). The Morris water maze tests also showed a tendency similar to the 
object recognition tests; the RNPN-treatment significantly shortened the acquisition time compared with other 
groups (Fig. 2E). The aforementioned results confirmed that the RNPN-treatment significantly improved the 
learning and memory dysfunctions in AD transgenic mice (p < 0.05) when compare to the water-treated, LMW 
TEMPO-treated, and nRNP-treated groups. It is interesting to note that the LMW TEMPO-treated group did not 
exhibit a strong improvement effect on the learning and memory functions than those of RNPN-treated mice, 
although it was detected in the brain using ESR measurements.
Suppression of oxidative stress in the brain by ad libitum drinking of RNPN solution. The lipid 
peroxide or malondialdehyde (MDA), 8-hydroxy-2′ -deoxyguanosine (8-OHdG) levels, the percent inhibition 
of superoxide anion (O2·−), and glutathione peroxidase (GPx) assays were used to determine the free radical 
scavenging capacity of RNPN in comparison with non-treated, water-treated, TEMPO-treated, and nRNP-treated 
groups. As shown in Fig. 3, RNPN treatment decreased MDA and 8-OHdG levels, while increasing percent 
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inhibition of O2·− and GPx activity when compared to the other treatment groups (p < 0.05), indicating the effec-
tiveness of RNPN treatment compared to LMW antioxidant treatment.
Decreased Aβ(1-40), Aβ(1-42), and γ-secretase levels in the brain and plasma of transgenic mice 
treated with ad libitum drinking of RNPN solution. As mentioned above, the formation and aggrega-
tion of Aβ(1-42) is more toxic, widespread, and abundant than Aβ(1-40)21. In addition, γ-secretase is a protease 
with substrates that cleave APP and catalyze Aβ aggregation via the amyloidogenic pathway22. We observed that 
Figure 1. The electron spin resonance (ESR) spectra of 4-amino-TEMPO standard in saline (A), 4-amino-
TEMPO in the blood after ad libitum drinking for 6 months (B) 4-amino-TEMPO in the brain after ad libitum 
drinking for 6 months (C) ESR spectra of RNPN in saline (D), RNPN in control brain (E), RNPN in the blood 
after ad libitum drinking for 6 months (F), and RNPN in brain after ad libitum drinking for 6 months (G).
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the levels of Aβ(1-40), (1-42), and γ-secretase in both the brain and plasma samples were significantly reduced 
after RNPN-treatment compared to AD mice treated with water, TEMPO, and nRNP (p < 0.05) as shown in Fig. 4.
Reduction in amyloid plaque formation by chronic ad libitum drinking of RNPN solution. To 
confirm amyloid plaque formation and/or aggregation in mice brain, thioflavin S and immunohistochemistry 
staining of Aβ(1-40) and Aβ(1-42) were carried out. From the representative photomicrographs of thioflavin 
S staining in the cerebral cortex, as shown in Fig. 5A, no remarkable Aβ fibrils was observed in wild-type mice 
(Fig. 5A-1), while transgenic mice in the water-treated group (Fig. 5A-2) showed remarkable Aβ fibrils in the 
cortex area. Although the LMW TEMPO treatment attenuated the number Aβ fibrils to some extent, AD mice 
Figure 2. The chronic effect of oral ad libitum RNPN treatment on object recognition test at mice age 10 (A) 
and 11 months (B), object location test at mice age 10 (C) and 11 months (D) after 1 h of administration and 
Morris water maze test at mice age 12 months (E). Data were represented as mean ± SEM, # vs. wild type mice, 
p < 0.05; ## vs. AD mice treated with TEMPO, p < 0.05; * vs. AD mice treated with water, p < 0.05; ** vs. AD 
mice treated with nRNP, p < 0.05; n = 10 mice/group.
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treated with RNPN showed much higher attenuation efficiency (Fig. 5A-4) (p < 0.05, Figs 5A-3,5), which was 
confirmed by the quantitative fluorescent intensity in Fig. 5B.
The immunostaining of Aβ(1-40) and Aβ(1-42) revealed no immunoreactive cells in the cerebral cortex of 
wild-type mice (Fig. 5C-1, E-1). On the contrary, in AD transgenic mice that were treated with water, numerous 
immunoreactive Aβ(1-40) and Aβ(1-42) positive cells were observed (Fig. 5C-2, E-2), similar to that after treat-
ment with nRNP (Fig. 5C-5, E-5). The RNPN-treated AD mice group showed significant reduction in Aβ(1-40) 
and Aβ(1-42) positive cells (Fig. 5C-4, E-4). This reduction was higher than that in the LMW TEMPO group 
(Fig. 5C-3, E-3), which are quantitatively confirmed as shown in Fig. 5D,F. For quantitative evaluation of number 
of plaques as shown in Fig. 5D,F, we employed randomly captured 5 slices per group under magnification of 20X 
(See Figure S5).
Discussion
We have designed an antioxidative treatment in a transgenic AD model mice (Tg2576) using our novel amphi-
philic polymer antioxidant, which self-assembles in aqueous media. Since the size of RNPN was approximately 
30-40 nm, we also confirmed that the volume of ad libitum drinking of RNPN solution was the same as in water, 
TEMPO, and nRNP-treated mice (data not shown). The triplet signals were observed in both the blood and 
brain samples of LMW TEMPO-administered group (Fig. 1B and C), suggesting that the blood brain barrier of 
these Tg2576 mice might be weakened at tight junctions between the endothelial cells due to the significant Aβ 
expression23. Immediately, after preparation via the dialysis method, the ESR signal of RNPN became broader, 
because of the restricted mobility of the nitroxide radicals in the solid state, which proves that the confinement 
of nitroxide radicals in the nanoparticle core (Fig. 1D). The ESR signals of RNPN changed its pattern from broad 
ESR spectra to triplet in the blood of mice with ad libitum drinking (Fig. 1F) due to its disintegration in the stom-
ach followed by absorption in the blood stream via mesentery in the small intestine. Because the redox polymer 
possesses cationic charge, it was previously confirmed to interact with serum proteins in the blood stream and 
circulate for an extended period19. By the ad libitum drinking of RNPN solution, the redox polymer continuously 
circulates in the bloodstream and gains access to the brain vessel walls continuously. This repeated access of the 
redox polymer improved the uptake in the brain as shown in Fig. 1G. The results of ESR signal intensity (a.u.) data 
Figure 3. The oral ad libitum treatment with RNPN improves oxidative stress parameters of MDA level (A), 
8-OHdG level (B), % inhibition of O2·− (C) and GPx activity (D). Data were represented as mean ± SEM, # 
vs. wild type mice, p < 0.05; ## vs. AD mice treated with TEMPO, p < 0.05; * vs. AD mice treated with water, 
p < 0.05; ** vs. AD mice treated with nRNP, p < 0.05; n = 5 samples/group.
www.nature.com/scientificreports/
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(Supplementary Table S1) exhibited that the brain of mice treated with RNPN (3.04 × 103 a.u.) has significantly 
higher ESR signal intensity than that of the LMW TEMPO-treated group (1.94 × 103 a.u.), which is probably due 
to the rapid elimination of LMW TEMPO.
Transgenic Tg2576 mice overexpressing human amyloid precursor protein (hAPP) are widely used as an 
AD mouse model to evaluate the treatment effects on Aβ pathology. Previous reports on the onset of cognitive 
deficits in Tg2576 have determined that abnormalities appear as early as 3 months and as late as 12 months24. In 
this study, the aged Tg2576 mice (approximate 7–12 months) were used for the evaluation of the learning and 
memory of AD mice; Morris water maze, novel object recognition and object location memory tests25–28. The 
transgenic mice we used in this study showed statistically significant reduction of the duration of both object 
recognition and location tests and elongation of acquisition time in Morris water maze test than that of wild-type 
Figure 4. The effect of ad libitum drinking of RNPN on Aβ(1-42) in the brain (A), the plasma (B), γ-secretase 
in the brain (C) and Aβ (1-40) in the brain (D), Aβ(1-40) in the plasma (E) of mice. Data were expressed as 
mean ± SEM, # vs. wild-type group, p < 0.05; * vs. AD mice treated with water, p < 0.05; ** vs. AD mice treated 
with nRNP, p < 0.05, n = 5 samples/group.
www.nature.com/scientificreports/
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mice, which is in accordance with the previous study where Tg2576 mice displayed impaired spontaneous alter-
nation of Y-maze test at both 3 and 10 months of age, as well as advanced impairment in the acquisition time of 
Morris water maze test in 9–10 months of AD mice29. We have previously reported that oral RNPN treatment 
recovered both cognition and memory levels in 17-week-old SAMP8 mice19. Here, RNPN-treated group extended 
the time in the object recognition and location tests and decreased the acquisition time in Morris water maze test, 
indicating the effective attenuation of the learning and memory deficits in AD transgenic mice (Tg2576) (Fig. 2). 
Taking together these results and our previous data on SAMP8, it suggests that our antioxidative nanoparticle 
treatment is robust strategy for AD therapy.
Oxidative stress has been implicated in Aβ accumulation and progression via mitochondrial dysfunction, 
which caused by the generation of ROS30, 31 and reduction in the level of detoxifying enzymes including superox-
ide dismutase (SOD), GPx and catalase (CAT) in the early stages of the AD32, 33. ROS destroys the polyunsaturated 
Figure 5. The effect of oral ad libitum drinking of RNPN on Aβ-fibrils using thioflavin S staining (A), semi-
quantitative analysis of Aβ-fibril (B), immunohistochemistry staining of Aβ(1-42) (C), semi-quantitative 
analysis of Aβ(1-42) (D), immunohistochemistry staining of Aβ(1-40) (E), and semi-quantitative analysis of 
Aβ(1-40) (F) of the cerebral cortex of mice brain; 1. wild type group; 2. AD mice group treated with water; 3. 
AD mice group treated with TEMPO; 4. AD mice group treated with RNPN; 5. AD mice group treated with 
nRNP; 6. negative control group. Data were expressed as mean ± SEM, # vs. wild-type group, p < 0.05; ## vs. AD 
mice treated with TEMPO, p < 0.05; * vs. AD mice treated with water, p < 0.05; ** vs. AD mice treated with 
nRNP, p < 0.05, n = 5 sample/group. White arrow indicates amyloid fibril and red arrow indicates amyloid 
plaque and scale bar = 100 μm.
www.nature.com/scientificreports/
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fatty acids of cellular membranes to generate lipid peroxidation products such as MDA, which may serve as an 
indicator of the level of oxidative damage32, 34, and induce neuronal deterioration35, 36. In addition, 8-OHdG has 
been determined as a pivotal biomarker of oxidative DNA damage37. Additionally, the toxic effect of Aβ peptide 
in neuronal cells has been proposed via the interaction between the peptide and Cu2+ and Fe3+ ions because Aβ is 
a metalloprotein that displays high-affinity binding to these ions, leading to amyloid plaque formation. Aβ cata-
lyzes the reduction of Cu2+ to Cu+ and Fe3+ to Fe2+, that produce hydrogen peroxide (H2O2)38–40. Furthermore, in 
AD transgenic mouse models of mutants of APP elevated production of H2O2 and nitric oxide increases protein 
and lipid peroxidation. These were associated with age-related Aβ accumulation, and Aβ further enhances oxida-
tive stress41. As expected, the observed neuroprotection by RNPN was due to its antioxidant properties through 
enhancement of the activity of GPx and percent inhibition of O2·−, while reducing MDA and 8-OHdG levels, 
compared to other AD groups (p < 0.05) as shown in Fig. 3. This was consistent with our previous result, where 
we showed that RNPN eliminates superoxide anion and hydroxyl radicals, which cause lipid peroxidation and 
protein and DNA oxidation19, 20.
Since RNPN possesses covalently conjugated TEMPO molecules, which scavenge superoxide radicals42 it 
directly reacts with both carbon-centered and peroxy radicals43 preventing the reduction of hydrogen peroxide 
to hydroxyl radical44. Hence, RNPN might attenuate the formation of hydroxyl radical and acts similarly to SOD. 
The LMW TEMPO compounds easily permeate the cell membrane and functions as an intracellular scavenger 
of O2·− and other radicals45, 46, which is in sharp contrast to our redox polymer because of no internalization in 
healthy cells due to the high molecular weight16. Although our redox polymer, PEG-b-PMNT was not internal-
ized in healthy cells, it was effective in APPsw/Tg2576 AD mice to attenuate oxidative damage and induced the 
recovery of the activities of the radical scavenging enzymes of GPx. The suppression of cell internalization ten-
dency of the redox polymer is one of the most important factors to suppress severe adverse side effects in healthy 
cells and tissues unlike the LMW TEMPO16. Recently, we have been investigating the effect and potential toxicity 
of RNPs (pH-sensitive RNPN and pH-insensitive RNPO), TEMPOL and nRNP to several animals. For example, 
when zebrafish larvae were exposed to 10–30 mM of LMW TEMPOL, all were dead after 12 h, whereas no larva 
death was observed after exposure to RNPs at the same high concentrations. By staining mitochondria from the 
larvae, we found that LMW TEMPOL significantly induced mitochondrial dysfunction. In contrast, RNPs did not 
cause any significant reduction in the mitochondrial function of zebrafish larvae16. Oral administration of RNPO 
to healthy mice did not cause any damage to intestinal microflora47. In addition, long-term oral administration 
of RNPO to xenograft-tumor-bearing mice coupled with anti-cancer drug did not cause any adverse effect but 
reduced diarrhea and other undesired phenomena48–50. Oral administration of RNPN to transgenic non-alcoholic 
steatohepatitis model mice suppressed liver fibrosis but cause no adverse effect51. On the basis of our alternative 
investigations, we have concluded that RNPs do not cause strong toxic and adverse effects. In contrast to con-
ventional antioxidants that can be internalized into healthy cells, which destroy its normal redox reactions (e.g., 
electron transport chain), the size of RNPs prevents its cellular internalization.
ROS are implicated in the formation of senile plaques in the brains of patients with AD, which may result in 
neuronal death30. As the result displayed that scavenging ROS by orally administered RNPN significantly attenu-
ates the neuronal loss in both the cerebral cortex and hippocampus when compared to other AD-treated groups 
(Supplementary Figures S2-3, p < 0.05).
The development of γ-secretase inhibitors has been explored as drugs for AD52. Our in vivo result shows that 
RNPN-treatment significantly reduced γ-secretase levels, followed by a decrease in Aβ-level compared to AD mice 
treated with water, TEMPO, and nRNP respectively (p < 0.05), as shown in Fig. 4, which is in accordance with the 
previous in vitro and knockdown experiments.
Finally, we confirmed amyloid plaque formation and/or aggregation via thioflavin S and immunohistochem-
istry staining of Aβ(1-40) and Aβ(1-42). The results shown in Fig. 5 display that chronic oral administration of 
RNPN significantly reduced Aβ plaques and/or fibril aggregation when compared to other AD treatment groups 
(p < 0.05). It has been reported that the accumulation of Aβ is through the interaction of soluble Aβ with metal 
ions, mainly Zn2+, Cu2+, and Fe3+ 38. The prevention of soluble Aβ formation by RNPN treatment inhibits Aβ 
aggregation.
Conclusion
Here, we confirmed that after ad libitum drinking of our pH-sensitive redox nanoparticle, RNPN, which is a 
self-assembling polymer antioxidant, RNPN is internalized in the brain and eliminates the increased oxida-
tive stress by scavenging ROS and attenuates cognitive deficits. The increased levels of Aβ and γ-secretase and 
radical-scavenging activity were decreased after RNPN treatments. Finally, the number of the thioflavin S-stained 
neurons was significantly higher in the RNPN-treated group than in other groups. On the basis of these obtained 
results in addition to our previous results on the senescence-accelerated mice-treated with RNPN, we suggest that 
RNPN may be a promising candidate for the treatment of brain disorders including AD therapy.
Methods
Drugs and reagents. Amino-2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO), 4-hydroxy-2,2,6,6-te-
tramethylpiperidine-1-oxyl (TEMPOL) were purchased from Sigma-Aldrich (MO, USA), Mouse Aβ(1-42), 
Aβ(1-40) and γ-secretase ELISA kits were bought from MyBioSource, Inc. (San Diego, USA), Oxidative DNA 
damage ELISA kit was purchased from Cell Biolab, Inc. (San Diego, USA), Liquid 3,3′-diaminobenzidine (DAB) 
substrate kit was bought from Life technologies Corp. (Waltham, USA) and primary anti-Aβ(1-42), Aβ(1-40) and 
secondary antibodies were purchased from Abcam Plc. (Tokyo, Japan). All other chemicals in this study, which 
are analytical-reagent grade, were purchased locally from Wako Pure Chemical Industries Ltd. Japan.
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Animals. Female APPSWE/hemi-rd1 Tg2576 and wild-type mice were used in this study (CLEA, Japan, Inc., 
Tokyo, Japan). They were housed in the experimental animal center of the University of Tsukuba under controlled 
temperature (23 ± 1 °C), humidity (50 ± 5%), and lighting (12 h light/dark cycles). The animals had unrestricted 
access to food and water. All the experiments were carried out in accordance with the guidelines for animal 
care and use of Faculty of Medicine, Tsukuba University and were approved by the animal ethics committee of 
the Institutional Animal Experiment Committee at the University of Tsukuba (Protocol number 13-407) and 
in accordance with the Regulation for Animal Experiments in our University and the Fundamental Guidelines 
for Proper Conduct of Animal Experiments and Related Activities in Academic Research Institutions under the 
jurisdiction of the Ministry of Education, Culture, Sports, Science, and Technology.
Biodistribution of RNPN in the blood and brain after ad libitum drinking. Tg2576 mice age approx-
imately 12 months old were anesthetized via an intraperitoneal injection of sodium pentobarbital (50 mg/kg) after 
6-month ad libitum drinking of RNPN solution (5 mg/mL/day) and LMW TEMPO (0.6 mg/mL/day). The blood 
and brain tissue were collected immediately after perfusion. Whole blood samples were subjected immediately to 
ESR measurement to quantify the drug levels. The brain tissue was immediately placed on ice and homogenized.
The ESR signals from the blood were recorded at room temperature using a Bruker EMX-T ESR spectrom-
eter operating at 9.8 GHz with a 100 kHz magnetic field modulation. Signals were collected with the following 
parameters: center field, 5000 G; sweep width, 7000 G; microwave power, 100.2 mW; receiver gain, 1 × 103; time 
constant, 81.92 ms; and conversion time, 160 ms and sweep time, 163.84 s. The blood samples were corrected at 
predetermined time points and subjected to the ESR.
The total amount of drug (nitroxide radicals + hydroxyamines) in the brain was estimated from X-band ESR 
spectrometer (JES-TE25X; JEOL, Tokyo, Japan) at room temperature after the oxidation of hydroxylamine by 
K3[Fe(CN)6], which was prepared at 200 mM as a stock solution. The ESR measurements were carried out under 
the following conditions: frequency, 9.41 GHz; power, 8.00 mW; field, 333.8 ± 5 mT; sweep time, 1.0 min; modu-
lation, 0.1 mT; time constant, 0.1 s.
Voluntary test fluids consumption. Fifty milliliters of drinking fluids were provided in 75 mL drinking 
bottles equipped with stainless steel spouts, placed on cage covers. During the first 5 days, mice were given water 
as their only drinking fluid from bottles replacement water tap system to habituate them. For the next 6 months 
(at 7–12 months of age), all mice were allowed drinking bottles containing RNPN (5 mg/mL), nRNP (5 mg/mL), 
LMW TEMPO (0.6 mg/mL), and water in each group. The consumption of the fluids and the body weights was 
recorded once a week, and the bottles were filled with fresh solutions.
Experimental design. We used 7 month-old female APPSWE/hemi-rd1 Tg2576 and their non-transgenic 
littermates or wild-type (WT) mice (40 Tg2576 mice and 10 WT mice; weight, 25 ± 2.0 g and 30 ± 2.0 g, respec-
tively) in this study. All Tg2576 mice were randomly assigned to various groups for RNPN (5 mg/mouse/day) or 
blank micelles (5 mg/mL/day) or LMW TEMPO (0.6 mg/mL/day) or vehicle (water) by unrestricted access from 
drinking bottles every day for a 6-month period. In the fourth and fifth month after ad libitum drinking, the ani-
mals were tested in object recognition and object location tests. In the last month of the experiment, we also tested 
the mice in the Morris water maze test. After 6 months of the experiment, 50 mice were sacrificed, and half of the 
brain tissues were used for the assays for soluble Aβ(1-40) and Aβ(1-42), γ-secretase activity, ROS production 
(MDA and DNA oxidation), ROS levels, scavenging enzyme activity (GPx activity), and the other halves were 
used for Aβ immunohistochemical, thioflavin S, and cresyl violet staining.
Plasma and brain collection. After their behavioral tests were finished, the mice were anesthetized with 
sodium pentobarbital (50 mg/kg i.p.); blood samples were kept to separate plasma, and brains were quickly iso-
lated. The tissues were prepared for biochemical, histological and immunohistochemical examinations and stored 
at −80 °C until determination.
Antioxidant enzyme assay. The glutathione peroxidase (GPx) activity was determined by the previous 
method of Hussain et al.53 based on that the activity was measured indirectly by a coupled reaction with glu-
tathione reductase. Oxidized glutathione, produced upon reduction of hydrogen peroxide by glutathione peroxi-
dase, was recycled to its reduced state by glutathione reductase and NADPH. The oxidation of NADPH to NADP+ 
was accompanied by a decrease in absorbance at 340 nm. The rate of decrease in the A340 nm was directly pro-
portional to the glutathione peroxidase activity. In the final 1 mL of the system mixture contained 48 mM sodium 
phosphate, 0.38 mM EDTA, 0.12 mN β-NADPH, 0.95 mM sodium azide, 3.2 units of glutathione reductase, 1 mM 
glutathione (GSH), 0.02 mM DL-dithiothreitol, 0.0007% H2O2, and the standard enzyme glutathione peroxidase 
solution or a homogenate brain sample. The glutathione peroxidase solution was used as a standard enzyme activ-
ity. The standard curve was plotted as the rate of A340 nm per minute against the GPx activity. One unit activity 
was defined as the amount of enzyme necessary to catalase the oxidation by H2O2 of 1 µmole of GSH to GSSG per 
minute at pH 7 at 25 °C. The data were reported in units of GPx per mg protein.
Reactive oxygen species (ROS) products assays. Lipid peroxidation (LPO) was measured by deter-
mining malonyldialdehyde (MDA) which have been used as an indicator of lipid peroxidation according to 
Ohkawa et al.54, were measured by using a commercial assay kit (BIOMOL International, USA). Each sample 
was homogenized (Potter-Elvehjem) in a 10-fold volume of ice-cold 20 mM pH 7.4 of PBS containing 0.5 mM 
butylated hydroxytoluene to prevent sample oxidation. The homogenized sample was centrifuged at 3,000 g at 
4 °C for 10 min, and a 200 µL aliquot of the supernatant was used to measure MDA plus HAE levels according to 
the instructions of the manufacturer. Values were standardized to micrograms of protein.
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Each sample was homogenized (Potter-Elvehjem) in a 10-fold volume of ice-cold 20 mM pH 7.4 of PBS 
containing 1% streptomycin sulfate and incubated for 30 min at room temperature. The nucleic acid precipi-
tates were removed by centrifuging at 6,000 g for 10 min at 4 °C to avoid erroneous contribution to a higher 
estimation of the carbonyl content from nucleic acid in the cells. The supernatant was used to measure protein 
levels according to the instructions of the manufacturer. The obtained values were standardized to milligrams 
of protein. Deoxyguanosine (dG) is one of the constituents of DNA and when it is oxidized, it is altered into 
8-hydroxy-2′-deoxyguanosine (8-OHdG). 8-OHdG is useful as a general DNA oxidation marker in the body. A 
commercial assay kit (Cell Biolab, Inc., San Diego,USA) was used in this measurement. Tissue homogenate and 
supernatant were used to measure 8-OHdG levels according to the instructions of the manufacturer. The obtained 
values were standardized to milligrams of protein.
Brain oxidative DNA damage determined by ELISA. The remained supernatant of mice’ brains were 
also analyzed of 8-hydroxydeoxyguanosine (8-OHdG) which is the common marker of DNA oxidative stress 
according to the protocol of product manual (Cell Biolab, Inc., San Diego, USA). First, prepared 8-OHdG coated 
plate, overnight at 4 °C. Washed, filled assay diluent to each well and incubated for 1 h at room temperature (RT). 
Removed the solution, added 50 µL of sample to the coated wells following with anti-8-OHdG antibody and incu-
bated on an orbital shaker for 1 h at RT. Washed properly, filled 100 µL of secondary antibody. Added substrate 
solution and inhibit reaction by stop solution. Eventually, read the absorbance at 450 nm on a spectrophotometer 
to compare to the standard curve of 8-OHdG.
Assay of superoxide anion level. The reaction mixture consisted of 10 mM phosphate buffer (pH 7.4) 
containing 0.1 mM xanthine, 0.1 mM EDTA, 0.1 mM nitroblue tetrazolium, and 0.1 unit xanthine oxidase (XO) 
at a final volume of 1 mL. The formation rate of formazan produced was determined from the slope of the absorb-
ance curve during the initial 2 min of the reaction at 560 nm. In order to analyze the anti-oxidation activity, each 
sample of different groups was added to the reaction mixture. The change of absorbance was compared with that 
of the control in the same time reaction, and anti-oxidation activity was calculated according to the following 
Equation (1)
= × −‑Anti oxidation activity (%) 100 (A B)/A (1)
where A and B are the rate of formazan formation in the absence and presence of sample, respectively.
Measurement soluble Aβ(1-40), soluble Aβ(1-42) and γ-secretase in brain tissue and 
plasma. The brain tissue from one brain hemisphere of each mouse was homogenized in PBS, pH 7.4 and cen-
trifuged at 1500 g for 15 min. The anticoagulated blood was drawn and spinned at 1000 g for 10 min. The super-
natants of both types of sample were collected and protein quantification was performed using the bicinchoninic 
acid (BCA) assay (Bio-Rad Laboratories, Hercules, CA). Samples were analyzed for soluble Aβ(1-40), Aβ(1-42) or 
γ-secretase (BioSource International, Inc., Camarillo, CA) according to the manufacturer’s instructions. Briefly, 
added 50–100 µL of samples to each well of pre-coated microtiter plate, mixed with 5–10 µL of balance solution, 
filled 50–100 µL of conjugate solution to each specimen and then incubated for 1 h at 37 °C on automated shaker. 
Washed properly, added substrate A and B respectively and then incubated for 10–15 min at 37 °C. Finally, the 
reaction was stopped by terminate solution and determine the optical density at 450 nm immediately to compare 
with the typical standard curve of mouse Aβ(1-40) or Aβ(1-42) or γ-secretase respectively.
Histopathology. Brain was isolated for immunohistopathology. The corrected tissues were fixed in 10% 
formalin solution. Paraffin blocks were prepared after completing the tissue processing in different grades of 
alcohol and xylene. Brain sections (5 µm) were prepared from paraffin blocks using microtome, stained with 0.5% 
cresyl violet according to Paxions and Chorles55. Images were taken using OLYMPUS camera connected to the 
microscope to examine gross cellular damage and neuronal density determination using Image JTM (NIH, MD, 
USA) software56.
Aβ plaque staining and quantification. The brain sections of 5 µm were also studied of immunohisto-
chemistry analysis for Aβ(1-40) and Aβ(1-42) respectively. Pre-heated slices with microwave in acetic solution, 
cool at RT, blocked with methanol and hydrogen peroxide solution for 30 min. Washed properly, prepared moist 
chamber, blocked with BSA and added primary anti-Aβ(1-40) and Aβ(1-42) respectively (1:100, 1:100 and 1:50) 
of each slices for overnight at RT. Washed again and incubated with secondary antibody conjugated-horseradish 
peroxidase (HRP) for 45 min. Developed color by using DAB kit and slices were represented as brown positive 
staining cells, compared to WT group and used without primary antibody as negative control group under light 
microscope (Olympus model BZ-X710 Keyence, Tokyo, Japan).
Thioflavin S staining and semi-quantification. This method is suitable for staining of Aβ fibrils fol-
lowing Schmidt et al.57. After tissue processing, sections were immersed into 0.25% potassium permanganate 
solution for 20 min, bleaching solution for 2 min, blocking solution for 20 min, 0.25% acetic acid for 5 s, dropped 
thioflavin S staining solution on slices for 3–5 min, washed by 50% ethanol and following distilled water. Mounted 
with glycerin and observed under fluorescent microscope (Olympus model BZ-X710 Keyence, Tokyo, Japan).
The behavioural tests. In this experiment using 3 behavioural tests for measuring cognition status. The 
Morris water maze test was selected as a method for the evaluation of the spatial learning and memory according 
to the Morris’s method58. A circular water tank (120 cm in diameter and 50 cm in height) was filled with water to 
a depth of 30 cm inside the tank; an escape platform (11 cm in diameter) was placed, with the top of 1 cm below 
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the water surface. The platform was in the middle of the target quadrant, and its position remained fixed during 
the experiment. Above the tank, a white floor-to-ceiling cloth curtain was drawn around the pool, and four kinds 
of black cardboard (circle, triangular, rhombus and square) were hung equidistantly on the interior of the curtain 
serving as spatial cues. Each mouse had daily sessions of one trial for 5 consecutive days. When they succeeded, 
mice were allowed to stay on the platform for 30 s. When the mice failed to find the platform within 60 s, they 
were assisted by the experimenter and allowed to stay the platform for the same time. Probe trials were performed 
after the last training session at 6 months after free drinking substance.
The object location test or spatial novelty was conducted according to Barker et al. with some modification59. 
One day before object location test, all mice were exposed for 30 min to the empty test box for habituation. The 
object location tests consisted of 2 trials which are sample phase (T1) and test phase (T2) with a 30 min interval 
between the 2 trials. In sample phase, mice were exposed to object O1 and O2, which were placed in the far cor-
ner of the area. The animal was allowed to explore both objects during a sample phase for 3 min and the amount 
of exploration of each object was recorded. After a delay of 30 min, the test phase was started. In the test phase, 
object O3 was placed in the same position as object O1 in the sample test while object O4 was placed in the corner 
adjacent to the original position of O2, so that object O3 and O4 were in diagonal corners. Thus, both objects in 
the test phase were equally familiar, but one was in a new location. The position of the moved object was coun-
terbalanced between mice. All measures experiments were made with the experimenter blind to the treatment 
status of each animal. The basic measure was the total time spent by mice exploring each object during T1 and T2 
trials. Exploratory behavior was defined as the animal directing the nose toward the object at a distance of <2 cm. 
Looking around while sitting or resting against the object was not considered as exploration. On object location 
task the amount of time exploring each object (object in the new location versus object in familiar position) is 
reported as an object discrimination ratio and calculated using the following Equation (2)
−(Exploration time of object in the new location Exploration time of object in
familiar location)/Total exploration time of both objects (2)
The object recognition task was performed in a circle open-field apparatus (60 cm in diameter and 50 cm 
in height). The objects used in this task were different in shapes, colors, and textures according to Antunes and 
Biala60. The open field and the objects were cleaned between each trial using 70% ethanol to avoid odor trails. 
Before the experiment day, the animals were allowed to acclimatize to the experimental environment. During 
habituation, the animals were allowed to freely explore the apparatus without objects for 5 min, once a day for 
three consecutive days before testing. On the experimental day, animals were submitted to two trials spaced. 
During the first trial (T1), animals were placed in the area containing the same two identical objects for an 
amount of time necessary to spend 15 s exploring these two objects in a limit of 4 min. Any mice which did not 
explore the objects for 15 s within the 4 min period were excluded from experiments. 1 h after exposing to the first 
trial, the animals were exposed to the second trial (T2). According to this trial, one of the objects presented in 
the first trial was replaced by an unknown object (novel object). Animals were placed back in the arena for 3 min, 
the total times which the animals spent to explore or directed the nose within 2 cm of the object while looking at, 
sniffing, or touching the novel object were recorded and recognized as total exploration time upon novel object.
Statistical analysis. All data are presented as mean ± SEM values. All data were analyzed by One-way anal-
ysis of variance (ANOVA), followed by Tukey’s post hoc test. Probability (p) value of less than 0.05 was considered 
significant. Statistical analysis was performed using SPSS 17.0 software package for Windows.
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